New Technology from Professor Zhao Gang's Team of Yinfeng Special Committee is Here! Low-Temperature Preservation Success Rate Expected to Improve
Release time:
2024-09-12
Recently, the Yinfeng Low-temperature Medicine Special Committee head, Professor Zhao Gang from the University of Science and Technology of China, and his team successfully developed a super-powerful low-temperature protection technology, specifically designed to protect mouse oocytes. What’s impressive about this technology? It can greatly improve the success rate of preserving oocytes at ultra-low temperatures, just like putting a highly protective and insulating "suit" on the oocytes.
For women who need to delay their fertility plans due to cancer treatment or other reasons, this is great news. Treatments like radiotherapy and chemotherapy can easily damage the ovaries, affecting the quality of the oocytes, and hence, fertility. But now, with the new technology from Professor Zhao Gang's team, women can face these challenges with more confidence.
Oocytes are particularly delicate; they have a large surface area and high water content, making them highly susceptible to freezing and osmotic pressure changes. Previous protection methods, though somewhat effective, were not good enough. Therefore, Zhao Gang's team came up with a new idea: they created a special nanocomposite material that acts like a tiny "ice shield." It prevents ice crystal formation and quickly melts any formed ice crystals, thus ensuring the safe preservation of oocytes at low temperatures.
Experimental results show that oocytes protected with this new material are not only well-preserved but also have a strong ability to develop into embryos later on. Moreover, the baby mice born from these oocytes are just as lively and adorable as healthy ones, with no differences!
The research by Professor Zhao Gang's team not only provides a new solution for preserving female fertility but also points the way to future clinical applications. This is truly a wonderful gift that science and technology have brought us!
Latest developments
The debut and discourse of the YinFeng Life Continuation Project not only served as an authoritative demonstration of its own ethical governance framework but also contributed practical wisdom toward establishing industry norms.
Yinfeng Foundation Honored as "2025 Public Welfare Donor" by Jinan Red Cross
Looking ahead, Yinfeng Foundation will use this recognition as an opportunity to further deepen its strategic collaboration with the Jinan Red Cross, expand cooperation in areas such as life health and emergency response, and continue to empower efforts to accelerate the construction of a "new, strong, excellent, rich, beautiful, and high-quality" modern socialist strong capital city, contributing even more Yinfeng strength to this endeavor.
The team successfully developed the CryoSIM platform, an intelligent microfluidics and deep learning-integrated system. This platform deeply integrates core technologies of deep learning and microfluidics to enable high-throughput, high-precision automated analysis of oocyte membrane permeability. It provides a novel technological tool for optimizing and advancing the clinical translation of oocyte cryopreservation techniques. Additionally, it offers an innovative practical paradigm for the application of artificial intelligence in low-temperature biomedicine and reproductive medicine.
Public Welfare Partnership: A Special Letter from the Jinan Red Cross
On the afternoon of January 30, 2026, the Jinan Red Cross presented a letter of special significance to the Shandong Yinfeng Life Science Public Welfare Foundation (hereinafter referred to as the Yinfeng Foundation).
World’s First Achievement Highlights Brand Leadership
In the future, Yinfeng Life Science Research Institute will continue to uphold its mission of "Dedicated to Medical Technology, Safeguarding Human Health." It will empower brand building with more original and pioneering scientific and technological achievements, contributing wisdom and strength to Shandong's goal of building a national regional innovation hub and promoting Chinese brands on the global stage.
Global First Ovarian Tissue Dual Activation Technology Debuts at 2025 Jinan Achievements Conference
Currently, the ovarian tissue dual activation technology has been successfully applied in clinical practice at Beijing University of Chinese Medicine Shenzhen (Longgang) Hospital, having treated over 400 patients with a treatment success rate of 70%. Over the next three years, Shandong Yinfeng Life Science Research Institute plans to use Jinan as a center to gradually expand the transformation and application of this technological achievement nationwide.
Yinfeng Life Continuation Plan
Address: Yinfeng Biotechnology Park, 1758 Gangyuan 6th Road, High-tech Zone, Jinan City, Shandong Province
Zip Code: 250102
Telephone: 0086-0531-88897351
Mobile: 0086-19953155515
Mobile website
Official WeChat Public Number
Links:Red Cross Society of China丨Shandong Red Cross Society丨Shandong Provincial Health Commission | Yinfeng Group| Yinfeng Biological Group
All rights reserved©Yinfeng Life Continuation Powered by www.300.cn SEO
